Effects of wortmannin, a novel myosin light-chain kinase inhibitor, on bile canalicular contraction in vitro and in vivo.
Scand J Gastroenterol
; 31(4): 391-7, 1996 Apr.
Article
em En
| MEDLINE
| ID: mdl-8726309
ABSTRACT
BACKGROUND:
The cytoskeletal system is believed to play an important role in normal bile formation. The effects of wortmannin, a new myosin light-chain kinase inhibitor, on bile canalicular contraction and bile flow have been observed.METHODS:
The bile canalicular contraction of cultured hepatocyte doublets was investigated, using an image analyzer with a phase contrast microscope, and the intracellular Ca2+ concentration was measured, using microscopic fluorometry. We also investigated bile flow by in vivo intraportal infusion of the drug in rats.RESULTS:
Treatment with wortmannin inhibited norepinephrine-induced canalicular contraction and caused a decrease in bile flow without changing systematic and portal blood pressure. Morphologic examination of the electron microscopic study showed that most bile canaliculi were dilated, with loss of microvilli, but no other apparent damage was seen in parenchymal hepatocytes.CONCLUSIONS:
These data suggest that the integrity of the phosphorylation system of myosin is essential for normal bile flow.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Canalículos Biliares
/
Quinase de Cadeia Leve de Miosina
/
Androstadienos
Limite:
Animals
Idioma:
En
Revista:
Scand J Gastroenterol
Ano de publicação:
1996
Tipo de documento:
Article
País de afiliação:
Japão